Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44,852Revenue $M20,314Net Margin (%)6.3Z-Score2.3
Enterprise Value $M55,122EPS $1.5Operating Margin %8.1F-Score8
P/E(ttm))17.3Cash Flow Per Share $5.9Pre-tax Margin (%)6.2Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %14.5Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %-1.3Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow7.3y-y EBITDA Growth Rate %103ROA % (ttm)2.7Higher Current Ratio y-yY
Dividend Yield %2.2Insider Buy (3m)0ROE % (ttm)5.6Less Shares Outstanding y-yN
Payout Ratio %38.0Shares Outstanding M851ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAMichael Price 2014-06-30 Add0.71%$48.69 - $54.06
($51.09)
$ 52.523%Add 28.73%500,000
TEVAGeorge Soros 2014-06-30 Reduce-1.59%$48.69 - $54.06
($51.09)
$ 52.523%Reduce -29.45%7,273,240
TEVAVanguard Health Care Fund 2014-06-30 Reduce-0.73%$48.69 - $54.06
($51.09)
$ 52.523%Reduce -40.54%7,344,400
TEVAJames Barrow 2014-06-30 Reduce-0.19%$48.69 - $54.06
($51.09)
$ 52.523%Reduce -18.5%10,868,770
TEVAGeorge Soros 2014-03-31 Add0.52%$39.88 - $50.22
($45.91)
$ 52.5214%Add 10.67%10,310,041
TEVADavid Dreman 2014-03-31 Add0.15%$39.88 - $50.22
($45.91)
$ 52.5214%Add 24.43%183,323
TEVAJohn Keeley 2014-03-31 Buy 0.04%$39.88 - $50.22
($45.91)
$ 52.5214%New holding, 47435 sh.47,435
TEVAGeorge Soros 2013-12-31 Add1.96%$36.59 - $41.7
($39.39)
$ 52.5233%Add 158.2%9,316,000
TEVAJames Barrow 2013-12-31 Add0.31%$36.59 - $41.7
($39.39)
$ 52.5233%Add 79.64%12,143,563
TEVAMichael Price 2013-12-31 Add0.26%$36.59 - $41.7
($39.39)
$ 52.5233%Add 14.29%400,000
TEVAGeorge Soros 2013-09-30 Buy 1.5%$37.43 - $41.27
($39.03)
$ 52.5235%New holding, 3608000 sh.3,608,000
TEVAVanguard Health Care Fund 2013-09-30 Add0.23%$37.43 - $41.27
($39.03)
$ 52.5235%Add 15.71%13,145,600
TEVADavid Abrams 2013-09-30 Sold Out -5.8%$37.43 - $41.27
($39.03)
$ 52.5235%Sold Out0
TEVARonald Muhlenkamp 2013-06-30 Reduce-0.99%$37.8 - $40.23
($38.94)
$ 52.5235%Reduce -41.05%169,660
TEVAGeorge Soros 2013-06-30 Sold Out -0.02%$37.8 - $40.23
($38.94)
$ 52.5235%Sold Out0
TEVAVanguard Health Care Fund 2013-03-31 Add0.21%$37.19 - $41.06
($38.57)
$ 52.5236%Add 13.37%11,361,300
TEVAJames Barrow 2013-03-31 Add0.2%$37.19 - $41.06
($38.57)
$ 52.5236%Add 64.42%7,078,456
TEVAJohn Burbank 2013-03-31 Sold Out -0.11%$37.19 - $41.06
($38.57)
$ 52.5236%Sold Out0
TEVAGeorge Soros 2013-03-31 Reduce-0.04%$37.19 - $41.06
($38.57)
$ 52.5236%Reduce -66.67%50,000
TEVAMichael Price 2012-12-31 Add1.36%$36.95 - $42.52
($39.94)
$ 52.5232%Add 250%350,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
TEVA Michael Price 2014-06-30500,0000.063.2+28.73%
TEVA Ronald Muhlenkamp 2014-06-30176,8550.021.6+0.81%
TEVA Jean-Marie Eveillard 2014-06-3020000
TEVA John Keeley 2014-06-3047,4350.010.05
TEVA Tom Gayner 2014-06-30694,0000.081
TEVA David Dreman 2014-06-30159,0900.020.63-13.22%
TEVA James Barrow 2014-06-3010,868,7701.280.77-18.5%
TEVA George Soros 2014-06-307,273,2400.852.9-29.45%
TEVA Vanguard Health Care Fund 2014-06-307,344,4000.861-40.54%
Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

    Quarterly/Annual Reports about TEVA:

      News about TEVA:

      Articles On GuruFocus.com
      George Soros Reveals His Largest Stake Jul 23 2014 
      George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR Jul 16 2014 
      Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd Jun 26 2014 
      Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
      Top Guru Held Asian Companies of the First Quarter Jun 03 2014 
      George Soros Reports Top Five Stocks May 23 2014 
      Richard Snow's Top Five Highlight Finance and Healthcare Sectors May 14 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Should You Buy Actavis? Mar 18 2014 
      Forest Laboratories' Recovery Mar 18 2014 


      More From Other Websites
      Worth the Money? Assessing Executive Pay at Specialty Drug Makers Aug 27 2014
      TEVA, VRX And AGN, Pushing Drugs Industry Downward Aug 25 2014
      New Rules For Hydrocodone: What You Should Know Aug 22 2014
      OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell... Aug 21 2014
      OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell... Aug 21 2014
      Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company Aug 19 2014
      Are Teva Pharmaceticals' Shares Poised for a Rebound? Aug 08 2014
      Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate... Aug 07 2014
      Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats Aug 07 2014
      OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief... Aug 07 2014
      OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief... Aug 07 2014
      3 Stocks Pushing The Drugs Industry Downward Aug 06 2014
      Did George Soros Sell His Stake In Israeli-Based SodaStream Because Of Political Reasons? Aug 04 2014
      5 Drug Companies Profiting From Generics Aug 04 2014
      Teva's Q2 Earnings & Revs Grow Y/Y, Updates Outlook Aug 01 2014
      Why Teva Pharmaceutical (TEVA) Stock Is Lower Today Jul 31 2014
      Teva Pharm raises full-year profit forecast after solid second quarter Jul 31 2014
      Teva Pharm shareholder optimistic of change despite losing vote Jul 31 2014
      [$$] Teva Pharmaceutical Swings to a Profit Jul 31 2014
      Teva Pharm Q2 profit, revenue up on generic launches Jul 31 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK